IBDEI141 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19588,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,19588,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,19589,0)
 ;;=382.9^^105^1233^49
 ;;^UTILITY(U,$J,358.3,19589,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19589,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,19589,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,19589,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,19590,0)
 ;;=614.9^^105^1233^50
 ;;^UTILITY(U,$J,358.3,19590,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19590,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,19590,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,19590,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,19591,0)
 ;;=486.^^105^1233^52
 ;;^UTILITY(U,$J,358.3,19591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19591,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,19591,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,19591,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,19592,0)
 ;;=136.3^^105^1233^51
 ;;^UTILITY(U,$J,358.3,19592,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19592,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,19592,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,19592,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,19593,0)
 ;;=601.9^^105^1233^56
 ;;^UTILITY(U,$J,358.3,19593,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19593,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,19593,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,19593,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,19594,0)
 ;;=590.80^^105^1233^57
 ;;^UTILITY(U,$J,358.3,19594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19594,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,19594,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,19594,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,19595,0)
 ;;=711.00^^105^1233^58
 ;;^UTILITY(U,$J,358.3,19595,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19595,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,19595,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,19595,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,19596,0)
 ;;=461.9^^105^1233^60
 ;;^UTILITY(U,$J,358.3,19596,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19596,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,19596,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,19596,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,19597,0)
 ;;=473.9^^105^1233^59
 ;;^UTILITY(U,$J,358.3,19597,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19597,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,19597,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,19597,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,19598,0)
 ;;=091.0^^105^1233^65
 ;;^UTILITY(U,$J,358.3,19598,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19598,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,19598,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,19598,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,19599,0)
 ;;=097.0^^105^1233^63
 ;;^UTILITY(U,$J,358.3,19599,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19599,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,19599,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,19599,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,19600,0)
 ;;=094.9^^105^1233^64
 ;;^UTILITY(U,$J,358.3,19600,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19600,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,19600,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,19600,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,19601,0)
 ;;=097.9^^105^1233^62
 ;;^UTILITY(U,$J,358.3,19601,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19601,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,19601,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,19601,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,19602,0)
 ;;=463.^^105^1233^66
 ;;^UTILITY(U,$J,358.3,19602,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19602,1,4,0)
 ;;=4^463.
 ;;
 ;;$END ROU IBDEI141
